Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - rosuvastatin calcium, quantity: 20.84 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; light magnesium oxide; microcrystalline cellulose; crospovidone; titanium dioxide; lactose monohydrate; hypromellose; triacetin; brilliant blue fcf aluminium lake; iron oxide red; quinoline yellow aluminium lake - btc rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate. ,prevention of cardiovascular events btc rosuvastatin is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low hdl-c, smoking, or a family history of premature coronary heart disease). btc rosuvastatin is indicated to:,? reduce the risk of nonfatal myocardial infarction ? reduce the risk of nonfatal stroke ? reduce the risk of coronary artery revascularisation procedures.,in patients with hypercholesterolaemia btc rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia). ,prior to initiating therapy with btc rosuvastatin , secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - rosuvastatin calcium, quantity: 41.68 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; lactose; light magnesium oxide; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; sunset yellow fcf aluminium lake; triacetin; brilliant blue fcf aluminium lake; allura red ac aluminium lake - btc rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate. ,prevention of cardiovascular events btc rosuvastatin is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low hdl-c, smoking, or a family history of premature coronary heart disease). btc rosuvastatin is indicated to:,? reduce the risk of nonfatal myocardial infarction ? reduce the risk of nonfatal stroke ? reduce the risk of coronary artery revascularisation procedures.,in patients with hypercholesterolaemia btc rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia). ,prior to initiating therapy with btc rosuvastatin , secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - rosuvastatin calcium, quantity: 5.21 mg - tablet, film coated - excipient ingredients: lactose; microcrystalline cellulose; magnesium stearate; crospovidone; light magnesium oxide; hypromellose; triacetin; titanium dioxide; lactose monohydrate; iron oxide yellow - btc rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate. ,prevention of cardiovascular events btc rosuvastatin is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low hdl-c, smoking, or a family history of premature coronary heart disease). btc rosuvastatin is indicated to:,? reduce the risk of nonfatal myocardial infarction ? reduce the risk of nonfatal stroke ? reduce the risk of coronary artery revascularisation procedures.,in patients with hypercholesterolaemia btc rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia). ,prior to initiating therapy with btc rosuvastatin , secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - 12170 - tubing extension set, intravenous administration - a collection of tubing (with or without clamps) intended to establish an extension of tubing where the standard length of the tubing in an intravenous (iv) administration set is insufficient. this is a single-use device.

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - 46383 - nerve-locating anaesthesia kit, continuous administration - for the continuous administration of an anaesthetic agent (not included) to function as a peripheral nerve-block. this is a single use device

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - 35833 - electric infusion pump administration set - for the intravenous delivery of anaesthetic drugs and intravenous infusion within general surgery, obstetrics, coronary care, neurosurgery and intensive care. this is a single use device

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - 58977 - basic intravenous administration set - non-invasive connectors designed to conduct fluids from an intravenous (iv) administration bag/bottle to an intravenous set during gravitational or pump administration to a patient's venous system. this is a single use device

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - 34842 - anaesthesia kit, epidural - for the administration of an anaesthetic agent (not included) for the management of pain. this is a single use device

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - 34842 - anaesthesia kit, epidural - a single use kit for the administration of an anaesthetic agent (not included) for the management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - 46542 - elastomeric infusion pump system - a single use device for the of continuous and/or bolus administration of analgesic medicines for intraoperative, post operative and chemotherapy medications for the management of pain.